CNTA
Price
$15.41
Change
-$0.07 (-0.45%)
Updated
Jul 25 closing price
Capitalization
2.06B
23 days until earnings call
ONWRF
Price
$4.60
Change
-$0.39 (-7.82%)
Updated
Jul 23 closing price
Capitalization
220.76M
Interact to see
Advertisement

CNTA vs ONWRF

Header iconCNTA vs ONWRF Comparison
Open Charts CNTA vs ONWRFBanner chart's image
Centessa Pharmaceuticals
Price$15.41
Change-$0.07 (-0.45%)
Volume$355.82K
Capitalization2.06B
Onward Med
Price$4.60
Change-$0.39 (-7.82%)
Volume$3.93K
Capitalization220.76M
CNTA vs ONWRF Comparison Chart in %
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. ONWRF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a StrongBuy and ONWRF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CNTA: $15.41 vs. ONWRF: $4.60)
Brand notoriety: CNTA and ONWRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 35% vs. ONWRF: 434%
Market capitalization -- CNTA: $2.06B vs. ONWRF: $220.76M
CNTA [@Biotechnology] is valued at $2.06B. ONWRF’s [@Biotechnology] market capitalization is $220.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileONWRF’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • ONWRF’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than ONWRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 5 TA indicator(s) are bullish while ONWRF’s TA Score has 5 bullish TA indicator(s).

  • CNTA’s TA Score: 5 bullish, 4 bearish.
  • ONWRF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CNTA is a better buy in the short-term than ONWRF.

Price Growth

CNTA (@Biotechnology) experienced а -1.78% price change this week, while ONWRF (@Biotechnology) price change was -6.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CNTA is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($2.06B) has a higher market cap than ONWRF($221M). CNTA YTD gains are higher at: -8.000 vs. ONWRF (-23.333).
CNTAONWRFCNTA / ONWRF
Capitalization2.06B221M932%
EBITDA-208.73MN/A-
Gain YTD-8.000-23.33334%
P/E RatioN/AN/A-
Revenue15MN/A-
Total Cash285MN/A-
Total Debt118MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CNTAONWRF
RSI
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
33%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
45%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
50%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
54%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
46%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
37%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
50%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
20%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 5 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TECHX21.370.04
+0.19%
WisdomTree Technology and Inn 100 DgtN/A
THOGX44.850.07
+0.16%
Thornburg Global Opportunities R6
BSGIX16.08N/A
N/A
Baird Small/Mid Cap Growth Institutional
FSRTX8.68N/A
N/A
Fidelity Advisor Strategic Real Ret M
VVOIX22.56N/A
N/A
Invesco Value Opportunities Y

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with NRIX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-0.45%
NRIX - CNTA
48%
Loosely correlated
-0.09%
CRNX - CNTA
47%
Loosely correlated
+1.91%
XENE - CNTA
44%
Loosely correlated
-2.29%
IMCR - CNTA
43%
Loosely correlated
-0.28%
OCUL - CNTA
42%
Loosely correlated
+2.43%
More

ONWRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONWRF has been loosely correlated with SHJBF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ONWRF jumps, then SHJBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONWRF
1D Price
Change %
ONWRF100%
N/A
SHJBF - ONWRF
42%
Loosely correlated
N/A
CNTA - ONWRF
24%
Poorly correlated
-0.45%
UCBJF - ONWRF
23%
Poorly correlated
+1.62%
INO - ONWRF
22%
Poorly correlated
-2.65%
VIGL - ONWRF
9%
Poorly correlated
N/A
More